CPT code 93581 denotes a percutaneous transcatheter ventricular septal defect (VSD) closure procedure, used to close a congenital opening between the heart’s lower chambers. The procedure involves venous catheter access (typically via the groin), contrast imaging of cardiac chambers, and placement of an implant to seal the septal defect. This code is central to reporting minimally invasive interventional cardiology management of selected congenital VSDs and carries implications for procedural authorization, hospital resource use, and device reimbursement nationally.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for when transcatheter VSD closure is performed, typical sites of service, and payer coverage considerations. The publication provides benchmarks for utilization and payment trends, summaries of relevant policy updates affecting interventional congenital heart procedures, and comparisons of reimbursement patterns across major national payers. It also outlines common billing and documentation points relevant to hospital and physician claims submission for this interventional cardiac service.

Data not available in the input: Associated taxonomies, specific ICD-10 diagnoses, related codes, and payer-specific reimbursement rates.